Human oral microbiome dysbiosis as a novel non-invasive biomarker in detection of colorectal cancer

Theranostics. 2020 Sep 18;10(25):11595-11606. doi: 10.7150/thno.49515. eCollection 2020.

Abstract

Background: The oral microbiome may play an important role in colorectal carcinogenesis. However, few studies have investigated the association between oral microbiome and the development of colorectal cancer (CRC). We aimed to investigate whether oral health-colorectal tumor association has an underlying microbial basis, in the quest for novel non-invasive biomarkers for CRC. Methods: We collected oral swab samples from 161 patients with CRC, 34 patients with colorectal adenoma (CRA), and 58 healthy volunteers. The oral microbiota was assessed using 16S rRNA sequencing. We characterized oral microbiome, identified microbial markers, constructed and validated colorectal tumor (CRA and CRC) classifier. Results: Oral microbial composition and diversity were significantly different among the three groups, and the CRA group had the highest diversity. Analysis of the functional potential of oral microbiota demonstrated that the pathway involving cell motility was overrepresented in the CRA and CRC groups relative to that in the healthy controls. Moreover, a random forest model was constructed based on oral microbial markers, which could distinguish the colorectal tumor groups from the healthy controls and achieve a powerful classification potential in the discovery and validation cohorts. Conclusion: This study suggests a potential association between oral microbiome dysbiosis and colorectal cancer. Oral microbiota-based biomarkers may be helpful in predicting the risks for the development of CRA and CRC.

Keywords: 16S rRNA; colorectal adenomas; colorectal cancers; oral microbiome.

Publication types

  • Observational Study
  • Research Support, Non-U.S. Gov't
  • Validation Study

MeSH terms

  • Adult
  • Aged
  • Biomarkers, Tumor / analysis*
  • Biomarkers, Tumor / genetics
  • Case-Control Studies
  • Colorectal Neoplasms / diagnosis*
  • Colorectal Neoplasms / epidemiology
  • Colorectal Neoplasms / microbiology
  • DNA, Bacterial / analysis
  • DNA, Bacterial / genetics
  • Dysbiosis / complications
  • Dysbiosis / diagnosis*
  • Dysbiosis / microbiology
  • Female
  • Gastrointestinal Microbiome / genetics*
  • Humans
  • Male
  • Middle Aged
  • Mouth Mucosa / microbiology*
  • Prospective Studies
  • RNA, Ribosomal, 16S / genetics
  • Risk Assessment / methods

Substances

  • Biomarkers, Tumor
  • DNA, Bacterial
  • RNA, Ribosomal, 16S